Mouse models of atherosclerosis

American Journal of the Medical Sciences

Volumn 323, Issue 1, 2002, Pages 3-10

  Daugherty, Alan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Atherosclerosis; Genetic manipulations; Lipoproteins; Mouse

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROGENESIS; ATHEROSCLEROSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE PREDISPOSITION; MEDICAL RESEARCH; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY;

EID: 0036080373     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200201000-00002     Document Type: Conference Paper

References (76)

1. Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study
2. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation
3. Fatty streak initiation in Watanabe heritable hyperlipidemic and comparably hypercholesterolemic fat-fed rabbits
4. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
5. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions
6. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions
7. Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous placque
8. Fatty streak expansion and maturation in Watanabe heritable hyperlipidemic and comparably hypercholesterolemic fat-fed rabbits
9. The rise of the mouse, biomedicine's model mammal
10. Insights into the pathophysiology of unstable coronary artery disease
11. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation
12. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation
13. Quantitative assessment of atherosclerotic lesions in mice
14. Quantitation of atherosclerosis in murine models: Correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice
15. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/-mice
16. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse
17. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H
18. Pathology of atherosclerosis in cholesterol-fed, susceptible mice
19. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice
20. Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse
21. Complex genetic control of HDL levels in mice in response to an atherogenic diet. Coordinate regulation of HDL levels and bile acid metabolism
22. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet
23. Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice
24. Protective role of interleukin-10 in atherosclerosis
25. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55
26. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoproteina
27. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet
28. Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (LRP)
29. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
30. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels
31. Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure
32. Type-III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein-E
33. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia
34. Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112, Cys142)
35. Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice
36. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human APOE*2
37. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia
38. Lipoprotein receptors: Therapeutic implications
39. Cellular pathology of progressive atherosclerosis in the WHHL rabbit
40. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery
41. Synthetic low and high fat diets for the study of atherosclerosis in the mouse
42. Massive xanthomatosis and atherosclerosis in cholesterol-fed low-density lipoprotein receptor-negative mice
43. Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression
44. Generation of mice carrying a mutant apolipoprotein-E gene inactivated by gene targeting in embryonic stem cells
45. Severe hypercholesterolemia and atherosclerosis in apolipoprotein-E-deficient mice created by homologous recombination in ES cells
46. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice
47. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
48. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
49. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression
50. Genetic background determines the extent of atherosclerosis in ApoE-deficient mice
51. Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: Evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism
52. Variability in cholesterol content in serum and aortic tissue in apolipoprotein E-deficient mice is comparable in inbred (129/Sv) and outbred (mixed 129/Sv and C57BL/6) mice
53. Spontaneously hyperlipidemic (SHL) mice: Japanese wild mice with apolipoprotein E deficiency
54. Familial apoliprotein E deficiency
55. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein
56. Molecular cloning of an apoliprotein B messenger RNA editing protein
57. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48
58. A mouse model of human familial hypercholesterolemia: Markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet
59. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: No accentuation by apolipoprotein(a)
60. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
61. A mouse model with features of familial combined hyperlipidemia
62. Decreased lesion formation in CCR2(-/-) mice reveals a role for chemokines in the initiation of atherosclerosis
63. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
64. Combined role of P- and E-selectins in atherosclerosis
65. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse
66. Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice
67. Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice
68. The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice
69. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice
70. Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice
71. Triggers, acute risk factors and vulnerable plaques: The lexicon of a new frontier
72. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3 Leiden transgenic mice
73. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis
74. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E